Skip to content

Kathleen D. Scott, Director at Dermata Therapeutics, sold DRMA on Jun 16, 2026

Data as of Oct 27

▼ SELL$1311 shares at $1.19Kathleen D. Scott DirectorDRMA Dermata Therapeutics, Inc.
Watch DRMA
Traded
Jun 16, 2026
Disclosed
Jun 16, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kathleen D. Scott, Director at Dermata Therapeutics, sold DRMA on Jun 16, 2026TRADEDDISCLOSED
DRMASimilar stocks (XLV — its sector index fund), rebased to DRMA's price on the disclosure day
DRMA since disclosure
−36.6%
after the sale
Similar stocks (XLV) since disclosure
+17.2%
XLV — its sector index fund

Change in closing price from Jun 16, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on DRMA →